News » Health » In Good Hands

In Good Hands

Pioritising patients’ safety and innovation Institut Jantung Negara (IJN) has carved a niche for itself in cardiovascular and thoracic care.
Published: 2013

Institut Jantung Negara Since its inception in 1992, Institut Jantung Negara (IJN), also known as the National Heart Institute, has been a premier cardiovascular and thoracic care centre in Malaysia, with an estimated 1.6 million outpatients and 166,000 inpatients. Led by the vision of positioning itself as a centre of excellence in cardiovascular and thoracic care, IJN believes in constant innovation. As a means to this means, the hospital boasts of a well-qualified and experienced team of cardiologists, cardiothoracic surgeons and anesthesiologists. In a year, on average, IJN performed 8,600 cardiac catheterizations and interventional procedures and 3,000 cardiac surgeries. The institute also boasts a driven electrophysiology and paediatric cardiology team and a heart (and lung) transplant team which have been involved in groundbreaking procedures such as pulmonary artery stenting, percutaneous closure of defects (atrial septal defects, patent ductus arteriosus and muscular ventricular septal defects), and heart and lung transplants. In 2009, IJN embarked on the Transcatheter Aortic Valve Implantation (TAVI) programme, making it the first Asian country to implant the CoreValve. In 2010, IJN introduced the FDA approved HeartMate II Mechanical Heart System as a destination therapy for patients with severe heart failure.

IJN has treated more than 1.6 million outpatients and 166,000 inpatients.

“The GCC holds immense potential as a market for cardiovascular and thoracic care. GCC’s population is expected to increase at a compound annual growth rate of around 3% by 2015, one of the highest in the world, which would further boost the number of overseas visitors to Malaysia seeking healthcare. These countries can play a defining role in ensuring the success of Malaysia’s healthcare sector by establishing an affiliation with IJN in providing expertise in cardiology and cardiothoracic care. We are also open to collaboration, strategic partnership and exchange of staff on management of heart centres. In fact, through active collaboration with leading international medical establishments such as the  Papworth Hospital (UK), Heart and Diabetes Centre (Bad Oeynhause, Germany) and Children’s Heartlink and Minneapolis (U.S.A.), we are introducing state-of-the-art clinical techniques. One can be assured of comprehensive cardiac rehabilitation programmes, which include physical and emotional support as well as diet counselling,” says Tan Sri Dato’ Seri Dr. Robaayah Zambahari, IJN CEO and MD. The possibilities as to how far science, technology and genuine care can help patients are endless. It is this growing trust that has established IJN as the premier provider for cardiovascular and thoracic care in the country.

Facebook Twitter Google+

Leave a Comment